health

MINISO Group Will Report December Quarter and Full Year 2024 Financial Results on March 21, 2025

GUANGZHOU,China,March 7,2025-- MINISO Group Holding Limited (NYSE: MNSO; HKEX: 9896) ("MINISO","MINISO Group" or the "Company"),a global value retailer offering a variety

Akeso Announces Completion of Patient Enrollment in The Phase III Clinical Trial of Cadonilimab for Adjuvant Treatment of High-Risk Recurrent Hepatocellular Carcinoma

HONG KONG,March 6,2025-- Akeso,Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce the completion of patient enrollment for its Phase III registrational clinical tria

USHOPAL Expands Global Luxury Beauty Portfolio with the Acquisition of French Skincare Icon PAYOT

SHANGHAI,March 4,2025-- USHOPAL Group continues to solidify its position as the first China-based luxury beauty group to emerge on the global stage,with an acquisition strategy that focuses on strong

GTS Techlabs and Peacom Announce Strategic Partnership to Transform Business Messaging at MWC Barcelona 2025

BARCELONA,Spain,March 5,2025-- GTS Techlabs,the technology arm ofGlobe Teleservices (GTS),a leading telecom solutioncompany,and Peacom have announced a strategic partnership at Mobile World Congress

Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance

Revenue grew 93.5% to $10.5 million in the fourth quarter and 40.9% year-over-year to $30.6 million in 2024

Global Industry Partners Jointly Release Net5.5G Best Practices & Deployment Guide Whitepaper

BARCELONA,Spain,March 5,2025-- At MWC Barcelona 2025,the Broadband Development Congress (BDC),hosted by the WBBA,was a resounding success. Themed "Smarter Broadband: Investment. Innovation. Intel

CStone Submits Clinical Trial Application in Australia for CS5001 (ROR1 ADC) in Combination with First-Line Standard-of-Care for DLBCL

PhaseIb trial to evaluate CS5001 in combination with R-CHOP as a first-line treatment for diffuse large B-cell lymphoma (DLBCL),aiming to reshape the standard-of-care landscape.

Akeso Announces Completion of Patient Enrollment in The Phase III Clinical Trial of Cadonilimab for Adjuvant Treatment of High-Risk Recurrent Hepatocellular Carcinoma

HONG KONG,March 6,2025-- Akeso,Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce the completion of patient enrollment for its Phase III registrational clinical tria

MOBILE OPERATORS ACCOUNT FOR 85% OF INVESTMENTS IN MOBILE INTERNET CONNECTIVITY INFRASTRUCTURE, NEW GSMA REPORT REVEALS

Governments should prioritise pro-investment policies to accelerate network expansion and strengthen digital economies

AXA Climate School nurtures young talents in Hong Kong

Empowering future leaders with essential skills to combat climate change HONG KONG,March 3,2025-- AXA Hong Kong and Macau("AXA") launched the AXA Climate School in 2022,aimingto empower youn

Home Previous 15 16 17 18 19 20 21 Next Tail

10 Items Per Page (Page 18 / 92) Total 913 Items

©copyright 2009-2020 Success Tips Daily      Contact Us   SiteMap